A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 98.10
GOOG 585.68
MSFT 43.51
BAC 15.43
FB 75.00

Recently Added

GEVO 0.71
SONS 3.80
BRK-B 127.42
PSX 81.64
P 25.84

Gaining Speed

SONS 3.80
GEVO 0.71
PSX 81.64
BRK-B 127.42
DARA 1.35

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!